PALO ALTO, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--While clinical development technologies have come a long way in recent years, research sponsors continue to struggle to connect disparate systems ...

Decentralized clinical trial technology firm Medrio teamed up with biometrics clinical research organization PHASTAR on using metadata for data visualization that the two companies hope will help with ...

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced that clinical data from a ...

Patients and providers often lack clinical decision tools to enable effective shared decision making. This is especially true in the rapidly changing therapeutic landscape of metastatic kidney cancer.

Waste and inefficiency in drug development are big problems. They can be hard to spot, especially when you are in the midst of the process. A new way of visualizing clinical trials might help. Some ...

Huron Life Sciences' trialRx service is enabled by a unique, proprietary data analytics and visualization tool that leverages a database of the 32 million unique data points available on the National ...

Software will aid optimizing pre-clinical data management in accordance with global standards and guidelines. SEND Explorer is a validated, web-based application that provides advanced viewing, data ...

Built directly into the elluminate ecosystem, the agents combine governed data with explainable intelligence to accelerate decisions eClinical Solutions LLC, a global provider of digital clinical ...

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/trial-workflows ...

In this post, we’ll highlight a few of our favorite visuals from 2025 and walk through how we made them and what makes them successful.

Patients and providers often lack clinical decision tools to enable effective shared decision making. This is especially true in the rapidly changing therapeutic landscape of metastatic kidney cancer.